Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt · Delayed Price · Currency is EGP 1.280
+0.010 (0.79%)
At close: Jun 4, 2026
EGX:MCRO Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 115.73 | -38.1 | -272.65 | 173.84 | 147.93 |
Depreciation & Amortization | 17.13 | 16.56 | 16.72 | 13.62 | 6.6 |
Other Amortization | 0.38 | 0.38 | 0.51 | 0.68 | - |
Loss (Gain) From Sale of Assets | - | 0.33 | 0.02 | - | - |
Asset Writedown & Restructuring Costs | - | - | 24.42 | - | - |
Loss (Gain) From Sale of Investments | - | -3.29 | - | - | - |
Provision & Write-off of Bad Debts | 29.58 | 35.68 | 98.43 | 3.15 | 0.5 |
Other Operating Activities | 31.37 | 37.03 | 47.87 | 20.5 | 20.47 |
Change in Accounts Receivable | -1.33 | -168.85 | 104.94 | -33.58 | -131.35 |
Change in Inventory | -20.15 | 20.44 | -67.65 | -73.12 | -19.33 |
Change in Accounts Payable | 44.68 | -18.57 | 20.25 | 27.74 | 16.69 |
Change in Other Net Operating Assets | -56.4 | 43.94 | -10.87 | 2.1 | 8.74 |
Operating Cash Flow | 160.99 | -74.45 | -38.01 | 134.93 | 50.26 |
Operating Cash Flow Growth | - | - | - | 168.47% | 9.39% |
Capital Expenditures | -42.48 | -12.32 | -6.44 | -5.3 | -5.81 |
Sale of Property, Plant & Equipment | 0.62 | - | 0.04 | - | - |
Cash Acquisitions | - | - | - | - | -1.5 |
Sale (Purchase) of Intangibles | - | - | - | -3.5 | - |
Investment in Securities | - | 3.29 | - | - | - |
Other Investing Activities | 9.39 | 5.77 | 1.98 | 2.8 | 1.5 |
Investing Cash Flow | -32.46 | -3.26 | -4.42 | -6.01 | -5.82 |
Short-Term Debt Issued | 97.37 | 226.81 | 293.77 | 286.33 | 7.25 |
Long-Term Debt Issued | 102.58 | 154.63 | - | - | - |
Total Debt Issued | 199.95 | 381.45 | 293.77 | 286.33 | 7.25 |
Short-Term Debt Repaid | -196.4 | -317.81 | -260.57 | -212.08 | - |
Long-Term Debt Repaid | -18.37 | -16.01 | -12.25 | -11.88 | -4.58 |
Total Debt Repaid | -214.78 | -333.83 | -272.82 | -223.96 | -4.58 |
Net Debt Issued (Repaid) | -14.82 | 47.62 | 20.95 | 62.37 | 2.67 |
Issuance of Common Stock | - | 21.82 | - | - | - |
Repurchase of Common Stock | - | - | -29.97 | -24.87 | - |
Common Dividends Paid | - | -4.7 | -60 | -40 | -46.82 |
Financing Cash Flow | -14.82 | 64.73 | -69.02 | -2.5 | -44.15 |
Net Cash Flow | 113.7 | -12.97 | -111.44 | 126.43 | 0.29 |
Free Cash Flow | 118.51 | -86.76 | -44.44 | 129.63 | 44.44 |
Free Cash Flow Growth | - | - | - | 191.66% | 14.31% |
Free Cash Flow Margin | 13.25% | -16.69% | -8.45% | 17.77% | 7.48% |
Free Cash Flow Per Share | 0.21 | -0.15 | -0.08 | 0.23 | 0.08 |
Cash Interest Paid | 27.37 | 32.22 | 25.27 | 10.14 | 6.26 |
Cash Income Tax Paid | 0.1 | 0.05 | 48.79 | 45.71 | 42.95 |
Levered Free Cash Flow | 67.9 | -99.42 | 84.42 | 75.76 | -1 |
Unlevered Free Cash Flow | 89.42 | -61.51 | 102.85 | 84.18 | 4.1 |
Change in Working Capital | -33.21 | -123.04 | 46.67 | -76.86 | -125.25 |